Case Comprehensive Cancer Center

Reshmi Parameswaran, MS, PhD, member of Case CCC's Immune Oncology Program, was awarded a two-year, $200,000 Established Investigator Grant by the National Scleroderma Foundation. The funding supports her research using BAFF CAR-T treatment for systemic sclerosis. Systemic scleroderma (SSc) is a ra...

This article originally appeared in the fall/winter 2023 edition of Think magazine. This semester, The Daily will share some of the articles from the latest edition of the magazine. View more stories at case.edu/think. Nearly a year ago, on Feb. 3, just before 9 p.m., Ashley McCollum heard a loud b...

Written by leading science researchers, editors, and journalists, reviews in Nature Cancer's 2023 in Review showcase the most exciting discoveries and the biggest challenges of the year. It's not surprising that research conducted in the lab run by Case CCC's Justin Lathia, PhD, Molecular Oncology P...

Uriel Kim, a student in the Medical Scientist Training Program in CWRU's SOM and an Associate Trainee Member of the Case CCC, plans to graduate this spring with his MD, although he doesn't lack a plethora of letters behind his name (BS, MPH, PhD, and pending MBA to name a few). The transplanted Col...

GLP-1 RAs aren't just for diabetes or weight loss anymore. They might also be effective in reducing the risk of colorectal cancer, thanks to a new study by Nathan Berger, member of Case CCC's Population and Cancer Prevention Program, and Rong Xu, member of the Cancer Genomics and Epigenomics Program...

Funding will advance novel approaches to treating cancer and diabetes-related blindness

Reshmi Parameswaran, PhD, MS, a member of Case CCC's Immune Oncology Program, has received the Dr. Ralph and Marian Falk Medical Research Trust award. The $1M was awarded to Parameswaran for her work in cancer cell therapy. It is to be used over three years to advance novel approaches to treating B-...

Case Western Reserve nursing researcher to study how to improve end-of-life care with $3.3 million National Cancer Institute grant More than 600,000 people in the United States will die of cancer this year, according to the National Cancer Institute (NCI). Many will receive care they didn’t want in...

Shearwood McClelland, MD, a member of Case CCC's Population and Cancer Prevention Program, is the corresponding author for the study "Disparities in access to radiotherapy among Hispanic/Latinx populations in the United States: How far have we left to go?" published in the Oct. 26, 2023, issue of th...

In collaboration with Case CCC's consortium partners University Hospitals and Case Western Reserve University, ReHeva Biosciences, a pharmaceutical startup specializing in naturally derived complex cancer therapies, and Phase 1 Safety Trial Principal Investigator Afshin Dowlati, MD, Case CCC's Assoc...